SCHEMBL4929255

SCHEMBL4929255

Cc1cc(=O)oc2c(CCO)c(N)ccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 7/20 0.55
▸ GAA P10253 6/20 0.55
▸ GFER P55789 1/20 0.55
▸ KDM4E B2RXH2 8/20 0.50
▸ ALDH1A1 P00352 5/20 0.50
▸ ERAP1 Q9NZ08 4/20 0.50
▸ MAPK1 P28482 4/20 0.50
▸ MCL1 Q07820 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ MAOB P27338 1/20 0.50
▸ RXFP1 Q9HBX9 1/20 0.50
▸ MGAM O43451 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ SI P14410 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ MGAM2 Q2M2H8 1/20 0.50
▸ KMT2A Q03164 3/20 0.48
▸ HPGD P15428 6/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927312 0.80 PDE4D (0.52) HSD17B10GAAGFERKDM4EALDH1A1
SCHEMBL4925486 0.78 ALDH1A1 (0.43) HSD17B10GAAGFERKDM4EALDH1A1
SCHEMBL4927376 0.73 ALPL (0.49) HSD17B10GAAKDM4EALDH1A1ERAP1
SCHEMBL8807829 0.72 HSD17B10 (0.56) HSD17B10GAAGFERKDM4EALDH1A1
SCHEMBL11079352 0.72 GAA (0.63) HSD17B10GAAGFERKDM4EALDH1A1
SCHEMBL4931518 0.72 ALDH1A1 (0.52) HSD17B10GAAKDM4EALDH1A1MAPK1
SCHEMBL17716513 0.72 HSD17B10 (0.55) HSD17B10GAAGFERKDM4EALDH1A1
SCHEMBL18155873 0.72 KDM4E (0.67) HSD17B10GAAGFERKDM4EALDH1A1
SCHEMBL8724340 0.71 GAA (1.00) HSD17B10GAAGFERKDM4EALDH1A1
SCHEMBL28213200 0.70 KMT2A (0.58) HSD17B10GAAGFERKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT HSD17B10 336/4885GAA 67/4885GFER 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback